Movember

What is Movember?

Movember is the month formerly known as November, where men and women across the globe join together to raise awareness and funds for men’s health, specifically prostate cancer, testicular cancer and men’s mental health.

Men (also known as Mo Bros) sign up online at Movember.com. Starting clean-shaven on November 1st, these men donate their face for 30 days by growing and grooming the best moustache they can muster. Mo Bros effectively become walking, talking billboards for men's health raising funds and awareness along the way. Women (also known as Mo Sistas) play a key supporting role by signing up as team captains, recruiting Mo Bros, helping to raise funds, and encouraging the men in their life to take action when it comes to their health.
 
Mo growth is seen around the globe each November. In 2014, official campaigns will be held in 21 countries across five continents.

Movember and Prostate Cancer Canada

Prostate Cancer Canada is proud to be one of Movember’s Canadian beneficiary partners; through this relationship we are advancing prostate cancer research and support services for men and their families living with the disease.

Learn more:

Movember funded programs
Movember.com


 
 
 

Support PSA Tests


Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Prostate cancer researchers develop personalized genetic test to accurately predict recurrence risk

TORONTO, ON - November 13, 2014 – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. More

Prostate Cancer Canada reminds men that early detection using ‘Smart Screening’ for prostate cancer

Toronto, ON – October 27, 2014 – Prostate Cancer Canada responds today to guidelines released from The Canadian Task Force on Preventive Health Care (CTFPHC) recommending that the Prostate Specific Antigen (PSA) test should be eliminated as a screening tool for prostate cancer. More


Click here for news archive